Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-002824
Filing Date
2025-02-03
Accepted
2025-02-03 21:01:44
Documents
1
Period of Report
2025-01-31

Document Format Files

Seq Description Document Type Size
1 form4-02042025_020240.html 4  
1 form4-02042025_020240.xml 4 3358
  Complete submission text file 0001415889-25-002824.txt   4761
Mailing Address 21823 30TH DR SE BOTHELL WA 98021
Business Address
SIEGALL CLAY B (Reporting) CIK: 0001167496 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39580 | Film No.: 25584757

Mailing Address 18702 N. CREEK PARKWAY SUITE 100 BOTHELL WA 98011
Business Address 18702 N. CREEK PARKWAY SUITE 100 BOTHELL WA 98011 610-321-3700
Immunome Inc. (Issuer) CIK: 0001472012 (see all company filings)

EIN.: 770694340 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)